Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PYPD•FDA accepts NDA for D-Plex₁₀₀ with priority review
July 29 (Reuters) - PolyPid Ltd PYPD.O:
- PolyPid announces FDA acceptance of NDA with priority review for D-Plex₁₀₀
- PolyPid - FDA sets PDUFA target action date of November 28, 2026 for D-Plex100
- PolyPid - FDA acceptance triggers $15 million milestone payment, completing $30 million in payments
